by Summary:
Experts say it means there are "fewer obstacles for the immune system to neutralise the virus with antibodies". The world's biggest pharmaceutical company, Johnson & Johnson, told Sky News last month it was confident it had formulated a COVID-19 vaccine and wanted to make available on a not-for-profit basis in 2021. The firm hopes to begin human trials in September, which could mean mass production by early next year. The HIV comparison is significant, as the research was done using special equipment previously provided by a grant from the Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery. Coronavirus: Vaccine hopes boosted as scientists find virus has 'low shielding'
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Experts say it means there are "fewer obstacles for the immune system to neutralise the virus with antibodies". The world's biggest pharmaceutical company, Johnson & Johnson, told Sky News last month it was confident it had formulated a COVID-19 vaccine and wanted to make available on a not-for-profit basis in 2021. The firm hopes to begin human trials in September, which could mean mass production by early next year. The HIV comparison is significant, as the research was done using special equipment previously provided by a grant from the Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery. Coronavirus: Vaccine hopes boosted as scientists find virus has 'low shielding'
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Jeremy Smith writes UK workers’ pay over 6 years – just about keeping up with inflation (but one sector does much better…)
Robert Vienneau writes The Emergence of Triple Switching and the Rarity of Reswitching Explained
Lars Pålsson Syll writes Schuldenbremse bye bye
Robert Skidelsky writes Lord Skidelsky to ask His Majesty’s Government what is their policy with regard to the Ukraine war following the new policy of the government of the United States of America.
Experts say it means there are "fewer obstacles for the immune system to neutralise the virus with antibodies".
The world's biggest pharmaceutical company, Johnson & Johnson, told Sky News last month it was confident it had formulated a COVID-19 vaccine and wanted to make available on a not-for-profit basis in 2021.
The firm hopes to begin human trials in September, which could mean mass production by early next year.
The HIV comparison is significant, as the research was done using special equipment previously provided by a grant from the Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery.